Given the interest in anti-TIGIT therapies in solid tumors, our purpose was to evaluate the degree of TIGIT expression on tumor-infiltrating T cells in RCC at different anatomic sites and relative to other cancer types. Here, TIGIT is linked to renal cell carcinoma.